Sign in
Explore the registryTrack Vsv-gp154's trials

A Study to Evaluate ATP150/ATP152/ATP162, VSV-GP154 and Ezabenlimab in Patients With Pancreatic Ductal Adenocarcinoma

VSV-GP154OngoingActive not recruitingPhase 1Open NCT05846516 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…